Suppr超能文献

正常循环的成年人类红细胞含有无活性的一氧化氮合酶(NOS)蛋白。

Normal circulating adult human red blood cells contain inactive NOS proteins.

作者信息

Kang E S, Ford K, Grokulsky G, Wang Y B, Chiang T M, Acchiardo S R

机构信息

Department of Pediatrics, University of Tennessee, Memphis 38163, USA.

出版信息

J Lab Clin Med. 2000 Jun;135(6):444-51. doi: 10.1067/mlc.2000.106805.

Abstract

Human red blood cells (RBCs) are considered to play a significant role in both blood pressure (BP) regulation and tissue oxygenation, because they can bind as well as release previously bound nitric oxide (NO) from hemoglobin (Hb) and other intracellular components. Two reports indicate that the human RBC possesses nitric oxide synthase (NOS) activity-by the accumulation of nitrite across a membraned chamber in one and by the hydrolysis of labeled L-arginine, presumably to labeled L-citrulline, in the other. Furthermore, NOS proteins have been identified by immunoblot in RBCs. If true, the presence of NOS activity would convert the human RBC to a donor with limited ability to bind exogenously generated NO. In considering the importance of the question of the presence or not of NO synthetic capacity of this cell in BP regulation and tissue perfusion, whether human RBCs are, indeed, able to hydrolyze L-arginine to L-citrulline, the coproduct of NO was explored. RBC samples collected from control subjects were assayed for NOS activity by incubation of homogenized cellular fractions with labeled tritiated L-arginine in the presence of 0.5 mmol/L NADPH. By this method, the amino acid coproduct of NO, tritiated L-citrulline, would be recovered in the supernatant after removal of unused substrate by cationic resin treatment. At first, activity appeared to be present in the RBC supernatant but not in the pellet. However, activity was not suppressed by known inhibitors of NOS, whereas activity was suppressed by norvaline, an inhibitor of arginase activity with no known effect on NOS. By contrast, RBC arginase activity was not inhibited by N(omega)-nitro-L-arginine, NG-methyl-L-arginine, or aminoguanidine, known inhibitors of NOS, but was inhibited by norvaline. The label recovered by thin-layer chromatography was determined not to be tritiated L-citrulline but was instead tritiated L-ornithine, the product of arginase activity. Thus the enzymatic hydrolysis of L-arginine was not caused by NOS but was a result of the action of the enzyme arginase, which abounds in this cell. However, proteins interacting with antibodies to the endothelial and inducible isoforms of NOS were detected in human RBCs by immunoblot. Together, these findings indicate that human RBCs collected from normal adult individuals possess proteins that react with monoclonal antibodies to the Inducible and endothelial isoforms of NOS, but the proteins are without catalytic activity.

摘要

人类红细胞(RBCs)被认为在血压(BP)调节和组织氧合中都发挥着重要作用,因为它们既能结合又能从血红蛋白(Hb)和其他细胞内成分中释放先前结合的一氧化氮(NO)。两份报告表明人类红细胞具有一氧化氮合酶(NOS)活性——一份报告通过在膜腔中积累亚硝酸盐来证明,另一份报告则通过标记的L-精氨酸的水解,推测生成标记的L-瓜氨酸来证明。此外,通过免疫印迹法在红细胞中鉴定出了NOS蛋白。如果这是真的,NOS活性的存在将使人类红细胞转变为一个对外源性生成的NO结合能力有限的供体。在考虑该细胞是否具有NO合成能力这一问题在血压调节和组织灌注中的重要性时,研究了人类红细胞是否确实能够将L-精氨酸水解为L-瓜氨酸,即NO的副产物。从对照受试者采集的红细胞样本,通过在0.5 mmol/L NADPH存在下,将匀浆的细胞组分与标记的氚化L-精氨酸孵育来检测NOS活性。通过这种方法,在通过阳离子树脂处理去除未使用的底物后,NO的氨基酸副产物——氚化L-瓜氨酸将在上清液中回收。起初,活性似乎存在于红细胞上清液中,而不存在于沉淀中。然而,活性并未被已知的NOS抑制剂所抑制,而活性被正缬氨酸抑制,正缬氨酸是一种精氨酸酶活性抑制剂,对NOS没有已知影响。相比之下,红细胞精氨酸酶活性未被NOS的已知抑制剂N(ω)-硝基-L-精氨酸、NG-甲基-L-精氨酸或氨基胍抑制,但被正缬氨酸抑制。通过薄层色谱法回收的标记物经测定不是氚化L-瓜氨酸,而是氚化L-鸟氨酸,即精氨酸酶活性的产物。因此,L-精氨酸的酶促水解不是由NOS引起的,而是精氨酸酶作用的结果,精氨酸酶在这种细胞中大量存在。然而,通过免疫印迹法在人类红细胞中检测到了与NOS的内皮型和诱导型亚型抗体相互作用的蛋白质。这些发现共同表明,从正常成年个体采集的人类红细胞含有与NOS诱导型和内皮型亚型单克隆抗体发生反应的蛋白质,但这些蛋白质没有催化活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验